floxuridine has been researched along with Carcinoma, Signet Ring Cell in 3 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Whether gastric cancer in young adults differs from gastric cancer in older patients has been a controversial issue." | 2.41 | Gastric cancer in very young adults: apropos four patients and a review of the literature. ( Fiehler, J; Höffken, K; Kath, R; Schneider, CP, 2000) |
| "Type 3 gastric cancer in the midgastric region was diagnosed, and the patient underwent surgery." | 1.33 | [A long-term survivor with stage IV gastric cancer due to postoperative weekly paclitaxel and 5'-DFUR combination therapy]. ( Fukasawa, T; Gotoh, H; Shoji, T; Taniwaka, K, 2006) |
| "She was diagnosed as having an advanced gastric cancer, which was unresectable because of liver metastasis, esophageal invasion and paraaortic lymph node metastasis." | 1.29 | [Unresectable gastric cancer followed by remarkably effective tumor disappearance and good quality of life for 10 months after CDDP/5'-DFUR combination chemotherapy--a case report]. ( Hoshino, K; Ikeda, H; Kamoshita, N; Kobayashi, J; Koyama, T; Morishita, Y; Nakamura, M; Tanaka, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukasawa, T | 1 |
| Shoji, T | 1 |
| Gotoh, H | 1 |
| Taniwaka, K | 1 |
| Hoshino, K | 1 |
| Nakamura, M | 1 |
| Kamoshita, N | 1 |
| Ikeda, H | 1 |
| Kobayashi, J | 1 |
| Tanaka, T | 1 |
| Koyama, T | 1 |
| Morishita, Y | 1 |
| Kath, R | 1 |
| Fiehler, J | 1 |
| Schneider, CP | 1 |
| Höffken, K | 1 |
1 review available for floxuridine and Carcinoma, Signet Ring Cell
| Article | Year |
|---|---|
Gastric cancer in very young adults: apropos four patients and a review of the literature.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cis | 2000 |
2 other studies available for floxuridine and Carcinoma, Signet Ring Cell
| Article | Year |
|---|---|
[A long-term survivor with stage IV gastric cancer due to postoperative weekly paclitaxel and 5'-DFUR combination therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Combined Modality Thera | 2006 |
[Unresectable gastric cancer followed by remarkably effective tumor disappearance and good quality of life for 10 months after CDDP/5'-DFUR combination chemotherapy--a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Esoph | 1996 |